BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4995249)

  • 1. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 2. [C1-inactivator from guinea pig serum-mechanism of action. I. Effect of the inactivator on C1 in free solution].
    Loos M; Opferkuch W; Wagner H
    Z Med Mikrobiol Immunol; 1971; 156(2):208-20. PubMed ID: 4995250
    [No Abstract]   [Full Text] [Related]  

  • 3. [C1-inactivator from guinea pig-serum mechanism of action. II. Effect of the inactivator on C1 in its bound form: EAC1, EAC14b and EAC14b2a].
    Loos M
    Z Med Mikrobiol Immunol; 1971; 156(2):221-32. PubMed ID: 5554814
    [No Abstract]   [Full Text] [Related]  

  • 4. C2--the second component of guinea pig complement: purification and physico-chemical characterization.
    Wagner H; Röllinghoff M
    Immunochemistry; 1970 Dec; 7(12):977-87. PubMed ID: 4100761
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of antibodies monospecifically reactive with the third component of guinea pig complement.
    Burkholder PM
    Int Arch Allergy Appl Immunol; 1970; 37(2):124-42. PubMed ID: 5411244
    [No Abstract]   [Full Text] [Related]  

  • 6. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.
    Thompson RA; Lachmann PJ
    J Exp Med; 1970 Apr; 131(4):629-41. PubMed ID: 4193934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.
    Goldlust MB; Shin HS; Hammer CH; Mayer MM
    J Immunol; 1974 Sep; 113(3):998-1007. PubMed ID: 4213402
    [No Abstract]   [Full Text] [Related]  

  • 9. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    Tamura N; Nelson RA
    J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
    [No Abstract]   [Full Text] [Related]  

  • 10. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of plasma kallikrein with the C1 inhibitor.
    Gigli I; Mason JW; Colman RW; Austen KF
    J Immunol; 1970 Mar; 104(3):574-81. PubMed ID: 5435787
    [No Abstract]   [Full Text] [Related]  

  • 12. A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.
    Mayer MM; Miller JA; Shin HS
    J Immunol; 1970 Aug; 105(2):327-41. PubMed ID: 5433696
    [No Abstract]   [Full Text] [Related]  

  • 13. A factor in guinea-pig serum with accelerating effect on immune immobilization of Treponema pallidum (IAF). Isolation, purification and differentiation from the known haemolytic complement components and from lysozyme.
    Müller F; Segerling M
    Immunology; 1974 Jul; 27(1):33-41. PubMed ID: 4604004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

  • 15. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-complement effects of two anti-inflammatory agents. Niflumic and flufenamic acids.
    Harrity TW; Goldlust MB
    Biochem Pharmacol; 1974 Nov; 23(22):3107-20. PubMed ID: 4216354
    [No Abstract]   [Full Text] [Related]  

  • 17. An analogue of guinea pig C8: in vitro generation and inhibitory activity.
    Stolfi RL
    J Immunol; 1970 May; 104(5):1212-9. PubMed ID: 5444338
    [No Abstract]   [Full Text] [Related]  

  • 18. The first component of guinea pig complement: hemolytic assays with EA, EAC4 and with rat and guinea pig late acting components.
    Opferkuch W; Rapp HJ; Colten HR; Borsos T
    Immunochemistry; 1971 Jun; 8(6):517-23. PubMed ID: 4997463
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 20. Resolution of the first component of guinea pig complement into three subunits, Clq, Clr and Cls, and their hybridization with human Cl subunits.
    Sassano FG; Colten HR; Borsos T; Rapp HJ
    Immunochemistry; 1972 Apr; 9(4):405-12. PubMed ID: 4624560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.